T Cells Antivenom Development Autoimmune Diseases Immune Response Viral Infections Vaccine Development Cancer Immunotherapy Hormone Therapy Hormonal Therapy Allergies Autoimmune Disorders Chronic Inflammation DNA Methylation Cancer Treatment CAR T Therapy Cytokines Antiviral Research Innate Immunity Immune Suppression Inflammatory Response Cancer Immunology Macrophages Long COVID Antibodies Immunologist Awards Interferon Infectious Diseases Cellular Analysis
A three-component cocktail derived from 18 years of self-immunization shows promise in preclinical trials against elapid venoms, with dog trials and viper research on the horizon.